Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
Volume 0.22M
Average 0.35M
RNA Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Atrium Therapeutics, Inc.NASDAQ: RNA
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets of $292.36M in Q1 FY2026
Q1 FY2026 total assets was $292.36M.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 278.35M USD
- Year-over-year change
- —
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 278.35M | — |
Total Assets vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Total Assets figures are available to compare.
Balance Sheet
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.